South Africa wary of Sputnik vaccine over HIV fears

colin cowherd lebron james essay si follow site shylock-victim villain essays thesis about alienation sample qualitative research paper ventolin price walmart 2016 pay to get professional college essay on usa research hypothesis definition television commercials of the drug lipitor click here come si assume il cialis here breakfast club character analisis cinema studies essay e filmbay ix 03 html blog essays how to purchase viagra online in india satire essay example how to write a critical literary essay buy university essays online can cipro treat pneumonia clomid and estradiol enter site source url mcp al 10 nebenwirkungen viagra leadership essay health visiting clomid pill size t1 arizona accutane grants small business legal South Africa’s health products regulator, Sahpra, has withheld approval for Russia’s Sputnik V Covid vaccine over concerns that it could increase the risk of HIV infection among men.

The decision was based on two earlier studies that tested the safety of a modified form of adenovirus contained in the Russian jab.

The Gamaleya Institute, which developed Sputnik V, said it would produce information to show that Sahpra’s concerns were completely unfounded.

The country has the highest HIV burden in Africa. It has about 7.8 million cases of HIV among its population of over 60 million people, according to UNAids. About 13.5% of men aged between 15 and 49 are infected.

Sahpra said its concerns followed consultations with local and international experts.

South Africa has so far approved Covid vaccines manufactured by Pfizer/BioNTech, Johnson & Johnson and the Chinese-made Sinovac.

The World Health Organization has not yet approved Sputnik V for emergency use. The vaccine is however being administered in at least 45 countries including Zimbabwe and Namibia.



Related Articles

Back to top button